Latest News

Axonics® Receives Technology Innovation Award from Medtech Insight

IRVINE, Calif.–(BUSINESS WIRE)–Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and bowel dysfunction, announced today that the Axonics r-SNM System was awarded the “Best Technological Innovation, Therapeutic Device” at the 2018 Medtech Insight Awards in partnership with the MedTech Conference being held this week in Philadelphia. The Medtech Insight Awards highlight dedication and innovation within




Related posts

Sleeping pills reduce suicidal thoughts in patients with severe insomnia

Newsemia

FDA Approves 1st Generic EpiPen

Newsemia

Reclaiming the everyday: the situational dynamics of the 2011 London Riots

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy